Delivery Order SPE2DB25D3002-SPE2DB25FLPVD
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,652.35 delivery order contract is for the supply of Dupixent 200 mg/1.14 ml pen medical products. The contract has an ultimate completion date of August 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,220.68, is for the delivery of Dupixent 300 mg/2 ml pen, a medication used to treat various medical conditions. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has a period of performance through January 29, 2025. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,556.73 firm fixed-price delivery order contract is for the supply of Dupixent 300 mg/2 ml pen, a prescription medication. The contract has an ultimate completion date of February 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, valued at $16,839.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 16, 2025. The contract covers the procurement of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $7,090.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pen 2 ml, a medical product, to support military healthcare programs. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The $14,117.12 contract is for the supply of Dupixent 300 mg/2 ml pen medication. This award is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,135.32, is for the provision of Dupixent 300 mg/2 ml pen, a specialty pharmaceutical product. The ultimate completion date for this order is May 6, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award, valued at $16,163.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pens, a specialty medication, with a completion date of November 1, 2024. The contract is a delivery order and has a firm fixed price pricing type. It is not designated as a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $47,157.90 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of July 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a wide range of...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $4,228.32 awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of the prescription medication Dupixent 300 mg/2 ml pen, with a period of performance ending on August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...